Özgeçmiş
Hematoloji
Hematolojik Onkoloji
Aferez
Kök Hücre Nakli
Sorularınız
Seminerler
Ders 2008
Homer
Linkler
Son Gelişmeler
Halk İçin Hematoloji
Aktiviteler
 
   
   
   

Geri


YABANCI BİLDİRİLER

16th Annual Meeting of European Bone Marrow Transplantation 1990, The Hague, Hollanda

  1. Şardaş OS, Koç H, İlhan O, Akan H, Beksaç M High Dose Chemotherapy and Autologous Bone Marrow Transplantation in Refractory Malign Lymphomas
  2. Şardaş OS, Beksaç M, Akan H, Koç H, İlhan O Imbalances within the Peripheral Blood Lymphocyte Subpopulation in the Reconstitution Phase After Allogeneic Bone Marrow Transplantation
  3. Şardaş OS, Koç H, İlhan O, Akan H, Beksaç M Family Mismatched Donors in Allogeneic Bone Marrow Transplantation


15th International Cancer Congress, 1990, Hamburg, Almanya

  1. Şardaş OS, Beksaç M, Akan H, Koç H, İlhan O Addition of Verapamil to overcome drug resistance in refractory hematological malignancies


11th Congress of the International Society of Haematology, 1991, Basel, İsviçre

  1. Şardaş OS, Beksac M, Koç H, Akan H, İlhan O, Gürman G,Özcan M, Güneyli A. Follow up of Allogeneic Bone Marrow Transplants with Granulocyte Colony Stimulating Factor, Tumor Necrosis Factor Alpha and Soluble Interleukin 2 Receptor Levels.
  2. Şardaş OS, İlhan O, Koç H, Beksac M, Akan H, Gürman G, Arslan Ö, Konuk N. Mitoxantrone+Etoposide and Mitoxantrone+High Dose Cytosine Arabinoside in Refractory or Early Relapsed Acute Leukemias.
  3. Şardaş OS, Beksaç M, İlhan O, Koc H, Akan H, Gürman G, Ertürk Ş, Güneyli A. Clinical Effects of Ciclosporin-A Containing Chemotherapy Protocols in Refractory Hematological Neoplasms.


17th Annual Meeting of the European Bone Marrow Transplantation,Italya

  1. Şardaş OS, Beksaç M, Koç H, İlhan O, Akan H Soluble Interleukin-2 Receptor and Tumor Necrosis Factor Levels following Bone Marrow Transplantation.
  2. Şardaş OS, Beksaç M, Koç H, Türker A, İlhan O, Akan H, Gürman G CMV Antigen Monitorization in Seropositive Allogeneic Bone Marrow Transplants


6th ECCO Meeting, 1991, Florence, Italy

  1. Şardaş OS, Koç H, Beksaç M, İlhan O, Akan H , Gürman G, Özcan M IFN-Alfa2b therapy and monitorization of serum sIL-2R, TNF, G-CSF and GM-CSF in Chronic myelogenous leukemia


24th Congress of the International Society of Haematology, 1992, Londra, İngiltere

  1. Koç H, Ataoğlu H, Şentürk T, Özsökmen D, Akan H, Beksaç M, İlhan O, Şardaş OS Prevention of Fungal Infections in Patients Receiving Remission Induction Chemotherapy for Acute Leukemia- Oral fluconazole vs. nystatin
  2. Beksaç M, Ertürk Ş, Akan H, Koç H, İlhan O, Güneyli A, Sardaş OS The Clinical correlations of serum Tumor Necrosis Factor-alfa levels in Acute Leukemias. A Predictor of Response and Relapse


12th Congress of the International Society of Haematology, 1993, Viyana, Avusturya

  1. Akan H, Koç H, Aydoğdu İ, İlhan O, Beksaç M, Konuk N, Uysal A A single center randomized study comparing the efficacy of Sulperazone+Amikacin vs Ceftazidime+Amikacin in febrile neutropenic patients
  2. Koç H, İlhan O, Beksaç M, Akan H, Konuk N, Gürman G, Arslan Ö, Aydoğdu İ Interferon alfa-2b treatment in chronic myelogenous leukemia
  3. İlhan O, Koç H, Beksaç M, Akan H, Aydoğdu I, Konuk N, Şardaş OS Treatment of Aplastic Anemia with immunsuppressive therapy: Preliminary report. İbni Sina Hospital experience
  4. Aydoğdu İ, İlhan O, Beksaç M, Koç H, Akan H, Konuk N, Uysal A Effect of chemotherapy on serum erythropoietin levels in acute leukemia patients
  5. İlhan O, Koç H, Akan H, Beksaç M, Konuk N, Araslan Ö, UysalA, Şardaş OS Synergistic effects of Mitoxantrone+High dose Ara-c combination in the treatment of adult refractory or early relapsed acute nonlymphoblastic leukemia


European Haematology Association Meeting, 1994, Brüksel, Belçika

  1. İlhan O, Özcan M, Beksaç M, Koç H, Akan H, Konuk N, Uysal A Treatment of Evans Syndrome with danazol and cyclosporine


18th Annual Meeting of the European Bone Marrow Transplantation, 1994, Harrogate, İngiltere

  1. Beksaç M, Koç H, Akan H, İlhan O, Gürman G, Konuk N Verapamil use in Autologous Bone Maroow Transplantation of Lymphoma patients (Preliminary report)
  2. İlhan O, Beksaç M, Koç H, Akan H, Gürman G, Konuk N, Uysal A GM-CSF in the treatment of Aplastic Anemia


25th Congress of International Society of Hematology, 1994, Cancun, Meksika

  1. İlhan O, Beksaç M, Koç H, Akan H, Gürman G, Konuk N, Uysal A Granulocyte-macrophage colony stimulating factor in the treatment of aplastic anemia
  2. Koç H, Akan H, Konuk N, İlhan O, Beksaç M, Gürman G, Avdoğdu İ, Avdıntuğ O Vasculitis in the patients with myelodysplastic syndromes.
  3. İlhan O, Özcan M, Koç H, Beksaç M, Akan H, Gürman G, Aydoğdu İ Danazol therapy in chronic ITP: the preliminary results of İbn-i Sina group.


Annual Meeting of American Society of Hematology (ASH), 1994, Nashville, ABD

  1. Akan H, Koç H, Beksaç M, İlhan O, Gürman G, Konuk N, Uysal A, Özcan M, The effect of HLA in the development of Venoocclusive disease in MHC matched adults undergoing allogeneic Bone Marrow Transplantation


19th Annual Meeting of the European Bone Marrow Transplantation, 1995, Davos, İsviçre

  1. Akan H, Koç H, Beksaç M, İlhan O, Gürman G, N. Konuk, A. Uysal.: The effect of HLA in the development of venoocclusive disease in MHC matched adults undergoing Allogeneic bone marrow transplantation.
  2. Gürman G, Koç H, Akan H, İlhan O, Beksaç M, N. Konuk, A.Uysal, M. Özcan, A Sunguroğlu.: Reinduction of remission by immunotherapy ın chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.


13th Meeting of International Society of Haematology, Eylül 1995, İstanbul, Türkiye

  1. İlhan O, Beksaç M, Koç H, Akan H, Keskin A, Arslan Ö, Gürman G, Özcan M, Konuk N, Uysal A HLA-DR frequency ın Turkish Aplastik anemia patients and the impact of HLA DR2 posıtıvıty ın response rate in patients receiving immunosuppressive therapy
  2. Koç H, Beksaç M, İlhan O, Uysal A, Akan H, Konuk N, Gürman G, Özcan M, Results of three remission induction protocols in denovo acute myelogenous leukemia. Ibni Sina Hospital experience
  3. Beksaç M, Koç H, İlhan O, Akan H, Özcan M,Konuk N, Uysal A, B Ataç, N Çakar Determination of engraftment origin following allogeneic bone marrow transplantation by fluorescent in situ hybridization
  4. İlhan O, Akan H, Koç H, Beksaç M , Gürman G, Önder A, Özcan M, Konuk N, Uysal A, Erdem C, Erdi H The incidence of graft versus host disease in allogeneic bone marrow transplantion in Ibni Sina hospital
  5. Akan H, Koç H, Önder A, Beksaç M, İlhan O, Gürman G, Özcan M, Konuk N, Uysal A Febrile neutropenic complications of bone marrow transplantation
  6. İlhan O, Koç H, Akan H, Gürman G, Beksaç M, Özcan M, Konuk N, Uysal A Hemorrhagic cystitis as a complication of Bone Marrow Transplantation
  7. Koç H, İlhan O, Akan H, Beksaç M, Gürman G, Özcan M, Konuk N, Uysal A Bone Marrow Transplantation activity ın Ankara University İbni Sina Hospital
  8. Koç H, Akan H, İlhan O, Beksaç M, Gürman G, Özcan M, Konuk N, Uysal A Allogeneic Bone Marrow Transplantation in patients with acute nonlymphoblastic leukemia
  9. Gürman G, Sencer H, Uysal A, Koç H, Akan H, İlhan O, Beksaç M, Konuk N, Özcan M, Hemorragic cystitis after bone marrow transplantation: the role of electron microscopy in differential diagnosis
  10. Koç H, Akman N, Tunal A, Ferhanoğlu B, Yücel I, İlhan O, Beksaç M, Aydın Y, Akan H, Özcan M, Konuk N, Aktuğlu G, Gürman G, Ülkü B. Interferon alfa 2b compared to ınterferon alfa2b plus chemotherapy for remission maintenance in multipl myeloma: A multicenter study
  11. İlhan O, Özcan M, Beksaç M, Akar H, Koç H, Akan H, Gürman G, Şengül Ş A case of Denovo AML together with lung cancer
  12. İlhan O, Beksaç M, Özcan M, Koç H, Akan H, Gürman G Treatment of refractory multipl myeloma with autologous whole blood transplantation


16th International Cancer Congress, 1994, Yeni Delhi, Hindistan

  1. Koç H, İlhan O, Aydoğdu İ, Gürman G, Akan H, Beksaç M, Konuk N Administration of MINE protocol in ıntermediate and high grade NonHodgkin's Lymphomas


Annual Meeting of American Society of Hematology (ASH), 1995, Seattle, ABD

  1. İlhan O, Arslan Ö, Koc H, Beksac M, Akan H, Gürman G, Özcan M, Konuk N, Uysal A. High dose epirubicin containing ceop regimen in intermediate or high grade Nonhodgkin's lymphoma
  2. Akan H, Şengül Ş, Beksaç M, Koç H, İlhan O, Gürman G, Özcan M. Soluble adhesion molecules during progenitor cell engraftment.
  3. Akan H, İlhan O, Gürman. Özcan M, Arslan Ö, Beksaç M, Konuk N, Uysal A Relationship between serum cytokine levels and aplasia period following high dose chemotherapy supported by granulocyte colony stimulating factor as a salvage chemotherapy without stem cell rescue in malignant lymphomas.


II. International Symposium on Febrile Neutropenia, 1995, Brüksel, Belçika

  1. Akan H, Koç H, Arslan Ö, Beksaç M, İlhan O, Gürman G, Özcan M, Üstün C, Konuk N, Uysal A. Febrile neutropenic complications in a bone marrow transplantation unit


22nd EBMT Meeting, 1996, Viyana, Avusturya

  1. Koç H, Gürman G, Akan H, Beksaç M, Konuk N, İlhan O, Özcan M, Arslan Ö, Uysal A Allogeneic Peripheral Blood Stem Cell transplantation
  2. Özcan M, Beksaç M, Akan H, Arslan Ö, koç H, İlhan O, Arat M, konuk N, Uysal A Serum Erythropoetin changes associated with erythroid and megakaryocytic engraftment after BMT
  3. İlhan O, Beksaç M, Koç H, Akan H, Arslan Ö, Gürman G, Özcan M, Konuk N, Uysal A HLA DR2 is more frequent among Turkish aplastic anemia patients responding to immunosuppressive therapy
  4. Beksaç M, Koç H, Akan H, İlhan O, Özcan M, Arslan Ö, Konuk N, Uysal A, Ataç B, Çakar N Interphase in situ hybridization for follow-up of engraftment origin and minimal residual disease in bone marrow transplant patients


27th Annual Meeting of European Group for Blood and Marrow Transplantation, 25-28 Mart 2001, Maastricht, Hollanda

  1. M.Arat, E.Soydan, Ö.Arslan, M Özcan, G.Gürman, N.Konuk, A.Uysal, M.Beksaç, O.İlhan, H.Koç, H.Akan. The long term follow-up of lymphoma patients with CBV regimen and autologous stem cell rescue: Ibni Sina experience. 27th Annual Meeting of European Group for Blood and Marrow
  2. M Özcan, M.Arat, G.Gürman, Ö.Arslan, P.Topçuoğlu, M.Beksaç, O.İlhan, N.Konuk, A.Uysal, H.Koç, H.Akan Treatment of steriod refractory GVHD with anti-thymocyte globulin


XIII. Congress of the European Society for Hemapheresis, 16-19 September, 2001, Rivedal Garda-Trento, Italy
  1. M.Arat, Ö.Arslan, M Özcan, G.Gürman, M.Beksaç, H.Koç, E.Ayyıldız, P.Topçuoğlu, K.Dalva, H.akan, T.Demirer, A.Uysal, N.Konuk, O.İlhan. Allogeneic peripheral blood stem cell apheresis: Ibni Sina experience.
  2. Ö.Arslan, M.Arat, M Özcan, G.Gürman, M.Beksaç, F.altuntaş, H.Koç, H.Akan, T.Demirer, A.Uysal, N.Konuk, O.İlhan. Autologous peripheral blood stem cell mobilization: Ibni Sina Experience.
  3. O.İlhan, M.Arat, Ö.Arslan, M Özcan, G.Gürman, K.Dalva, M.Beksaç, T.Demirer, N.konuk, A.Uysal, H.Koç, H.Akan. Evaluation of mobilization efficacy of cyclophosphamide (Cy) based regimen by peripheral blood CD34+ cell quantification. XIII. Congress of the European Society for Hemapheresis, 16-19 September, 2001, Rivedal Garda-Trento, Italy, S:192
  4. T.Demirer, M. Aylı, M Özcan, R.Haznedar, T.Fen, M.Dağlı, Y.Genç, S.Dinçer, Ö.Arslan, O.İlhan, T.Üstün. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony stimulating factor (rhG-CSF): A randomized evaluation of different doses of rhG-CSF.
  5. Ö. Arslan, M Arat, İ. Tek, N. Yücemen, G. Kınıklı, M. Oral, E. Ayyıldız, A. Çiftçi, O. İlhan Therapeutic Plasma Exchange In A Single Center: Ibni Sina Experience
  6. O İlhan, M Arat, Ö Arslan, K Dalva, ŞM Bakanay, P Topçuoğlu, E Ayyıldız, A Çiftçi, H Akan. The Effect Of Preapheresis Dendritic Cell Counts On The Stem Cell Product (sözel)
  7. M Arat, Ö. Arslan, F. Altuntaş, E. Ayyıldız, A. Çiftçi, T. Demirer, O. İlhan Stem Cell Mobilization With Cyclophosphamide (Cy) Based Regimen In Multiple Myeloma: Ibn-I Sina Experience
  8. O. İlhan, Ö. Arslan, M Arat, A. Çiftçi, E. Ayyıldız, H. Şanlı, K. Dalva, H. Akan Short-Term Extracorporeal Photoimmunotherapy For Treatment Of Refractory Progressive Chronic Graft Versus Host Disease: Observations In Five Patients
  9. M Arat, Ö. Arslan, A. Çiftçi, K. Dalva, E. Ayyıldız, O. İlhan The Value Of G-Csf At Collection Of Donor Lymphocytes For Cellular Immunotherapy (sözel)
  10. İ. Tek, Ö. Arslan, İ. Çiftci, M Arat, E. Ayyıldız, A. Çiftçi, N. Yücemen, N. Mutluer, O. İlhan Effects Of Replacement Fluids On Plasma Viscosity Used For Therapeutic Plasma Exchange


44rdAnnual Meeting of American Society of Hematology, December 6-10, 2002, Philadelphia.
  1. Akyerli CB, Beksac M, Holko M, Frevel M, Dalva K, Gürman G, İlhan O, Özcan M, Akana H, Williams BRG, Özçelik T. Analysis of high and low risk chronic myeloid leukemia by gene expression profiling. 44rdAnnual Meeting of American Society of Hematology, December 6-10, 2002, Philadelphia. Blood 2002: 99;365a, (poster 1412)
  2. M.Beksac, M. Özcan, A.Tunalı, S.Dündar, M.Bayık, S.Paydaş, R.Ali, Y.Büyükbaşık, O.İlhan, F.Özkalemkaş, G.Gürman, A.Uysal, H.Akan, E.Akcaglayan, O.Özdemir. Outcome is worse in male compared to female de novo AML patients and can be improved with the use of granulocyte colony stimulating factor (G-CSF) during induction. Results of a randomized multicenter trial (Turkish Leukemia Study Group, TLG95-002). 44rdAnnual Meeting of American Society of Hematology, December 6-12, 2002, Philadelphia. Blood 2002:99; 251b, (4527)
  3. Beksac M, Arat M, Dalva K, İlhan O, Gürman G, Özcan M, Arslan Ö, Konuk N, Uysal A, Akan H. Molecular response rates achieved in chronic myelogenous leukemia (CML) patients treated with interferon, imatinib mesylate (STI) or stem cell transplantation. A single institutional experience. 44rd Annual Meeting of American Society of Hematology, December 6-12, 2002, Philadelphia. Blood 2002: 99;334b (4886)
  4. O. İlhan, M Arat, Ö Arslan, K Dalva, E Ayyıldız, H Akan. Preapheresis Dendritic Cell Count Predicts Apheresis Content In Allogeneic PBSC Collection. 44rd Annual Meeting of American Society of Hematology, December 6-12, 2002, Philadelphia. Blood 2002;100 (suppl: part 1 of 2) Abstract: 3276

    9th Congress of the World Apheresis Association. 7-10 September 2002, Paris, France
  5. M.Arat, K.Dalva, Ö.Arslan, G.Gürman, M Özcan, O.İlhan. Does G-CSF have any role of at collection of donor lymphoctes (DL) for cellular immunotherapy.
  6. O.İlhan, M.Arat, Ö.Arslan, M Özcan, G.Gürman, A.Çiftçi, M.Beksaç, H.Koç, E.Ayyıldız, H.Akan. Extracorporeal photoimmunotherapy (ECP) for treatment of steroid refractory progressive chronic graft versus host disease (CGVHD).
  7. M.Arat, Ö.Arslan, M Özcan, G.Gürman, M.Beksaç, H.Koç, E.Ayyıldız, P.Topçuoğlu, K.Dalva, H.Akan, T.Demirer, A.Uysal, N.Konuk, O.İlhan. Content of stem cells collected from healthy donors for allogeneic transplantation: Excess CD3 hazard.
  8. Ö.Arslan, M.Arat, M Özcan, G.Gürman, M.Beksaç, H.Koç, H.Akan, A.Uysal, N.Konuk, O.İlhan. The feasibility of tailoring autologous peripheral blood stem cell collections according to peripheral blood CD34 counts.
  9. O. İlhan, M Arat, Ö Arslan, K Dalva, ŞM Bakanay, P Topçuoğlu, E Ayyıldız, A Çiftçi, H Akan. Preapheresis prediction of dendritic cell content in allogeneic transplants (sözlü bildiri).
  10. Ö. Arslan, M Arat, İ. Tek, N. Yücemen, G. Kınıklı, M. Oral, E. Ayyıldız, A. Çiftçi, O. İlhan Therapeutic plasma exchange in a single center: Ibni Sina Experience.
[Devam]


[Başa Dön]